 SOUTH SAN FRANCISCO, Calif., Aug. 5, 2021 PRNewswire -- Vaxart, Inc. Nasdaq: VXRT issued its business update today for the second quarter of 2021, reporting strong forward momentum in development of oral tablet vaccines that it believes can revolutionize public health. 